An engineered hydrogel with low-dose antitumor drugs enhances tumor immunotherapy through tumor interstitial wrap
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Bioengineering and Biotechnology"
DOI: 10.3389/fbioe.2022.1072393
Abstract: Stimulating immunogenic cell death (ICD) is the key to tumor immunotherapy. However, traditional chemoradiotherapy has limited effect on stimulating immunity and often requires repeated administration, which greatly reduces the tumor-killing effect. In this article, we… read more here.
Keywords: engineered hydrogel; tumor immunotherapy; wrap; tumor ... See more keywords